1. Home
  2. INSM vs SN Comparison

INSM vs SN Comparison

Compare INSM & SN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INSM
  • SN
  • Stock Information
  • Founded
  • INSM 1988
  • SN 1993
  • Country
  • INSM United States
  • SN United States
  • Employees
  • INSM N/A
  • SN N/A
  • Industry
  • INSM Biotechnology: Pharmaceutical Preparations
  • SN
  • Sector
  • INSM Health Care
  • SN
  • Exchange
  • INSM Nasdaq
  • SN Nasdaq
  • Market Cap
  • INSM 19.1B
  • SN 16.7B
  • IPO Year
  • INSM 2000
  • SN N/A
  • Fundamental
  • Price
  • INSM $103.95
  • SN $120.30
  • Analyst Decision
  • INSM Strong Buy
  • SN Strong Buy
  • Analyst Count
  • INSM 17
  • SN 8
  • Target Price
  • INSM $109.20
  • SN $127.25
  • AVG Volume (30 Days)
  • INSM 4.1M
  • SN 1.6M
  • Earning Date
  • INSM 08-07-2025
  • SN 08-07-2025
  • Dividend Yield
  • INSM N/A
  • SN N/A
  • EPS Growth
  • INSM N/A
  • SN 133.24
  • EPS
  • INSM N/A
  • SN 3.16
  • Revenue
  • INSM $381,030,000.00
  • SN $5,685,049,000.00
  • Revenue This Year
  • INSM $28.17
  • SN $16.74
  • Revenue Next Year
  • INSM $120.09
  • SN $11.53
  • P/E Ratio
  • INSM N/A
  • SN $38.08
  • Revenue Growth
  • INSM 20.77
  • SN 27.34
  • 52 Week Low
  • INSM $60.40
  • SN $60.50
  • 52 Week High
  • INSM $106.83
  • SN $123.00
  • Technical
  • Relative Strength Index (RSI)
  • INSM 66.75
  • SN 78.63
  • Support Level
  • INSM $101.55
  • SN $117.80
  • Resistance Level
  • INSM $103.74
  • SN $121.05
  • Average True Range (ATR)
  • INSM 2.58
  • SN 2.91
  • MACD
  • INSM -0.49
  • SN 0.55
  • Stochastic Oscillator
  • INSM 86.11
  • SN 95.45

About INSM Insmed Incorporated

Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the US for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.

About SN SharkNinja Inc.

SharkNinja Inc is a product design and technology company that creates 5-star-rated lifestyle solutions through inventive products for consumers around the world. Its product categories include Cleaning, Cooking, Food Preparation, Home Environment and Beauty products. It sells vacuum cleaners, cooking pots, fryers, hair dryers, etc. The SharkNinja Group is expected to carry on the design, production, marketing, and distribution of the Shark and Ninja brands of small household appliances in North America, Europe and other selected international markets (excluding the Asia Pacific Region and Greater China). Currently, the majority of the revenue is derived from the U.S. market.

Share on Social Networks: